中文名 | 2-(4-((2-(4-(三氟甲基)苯基)-5-甲基噻唑-4-基)甲基硫基)-2-甲基苯氧基)乙酸 |
英文名 | 2-(4-((2-(4-(Trifluoromethyl)phenyl)-5-methylthiazol-4-yl)methylthio)-2-methylphenoxy)acetic acid |
别名 | 化合物GW501516 2-(4-((2..苯氧基)乙酸 2-(4-((2-(4-(三氟甲基)苯基)-5-甲 2-(4-((2-(4-(三氟甲基)苯基)-5-甲基噻唑-4-基)甲基硫基)-2-甲基苯氧基)乙酸 2-(2-甲基-4-(((4-甲基-2-(4-(三氟甲基)苯基)噻唑-5-基)甲基)硫代)苯氧基)乙酸 2-(2-甲基-4-(((4-甲基-2-(4-(三氟甲基)苯基)噻唑-5-基)甲基)硫基)苯氧基)乙酸 2-(4-((2-(4-(三氟甲基)苯基)-5-甲基噻唑-4-基)甲基硫基)-2-甲基苯氧基)乙酸 GW-501516 317318-70-02-(4-((2-(4-(三氟甲基)苯基)-5-甲基噻唑-4-基)甲基硫基)-2-甲基苯氧基)乙酸 |
英文别名 | GW501516 GW 501516 CB6465728 GW-501615 GW-501516 Cardarine(GW501516, GSK-516) 2-(4-((2-(4-(Trifluoromethyl)phenyl)-4-methylthiazol-5-yl)methylthio)-2-methylphenoxy)acetic a 2-(4-((2-(4-(Trifluoromethyl)phenyl)-5-methylthiazol-4-yl)methylthio)-2-methylphenoxy)acetic acid {2-Methyl-4-[4-Methyl-2-(4-trifluoroMethyl-phenyl)-thiazol-5-ylMethylsulfanyl]-phenoxy}-acetic acid Acetic acid, (2-methyl-4-(((4-methyl-2-(4-(trifluoromethyl)phenyl)-5-thiazolyl)methyl)thio)phenoxy)- 2-[2-methyl-4-[[4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl]methylsulfanyl]phenoxy]acetic acid {2-methyl-4-[({4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl}methyl)sulfanyl]phenoxy}acetic acid |
CAS | 317318-70-0 |
EINECS | 1592732-453-0 |
化学式 | C21H18F3NO3S2 |
分子量 | 453.5 |
InChI | InChI=1/C21H18F3NO3S2/c1-12-9-16(7-8-17(12)28-10-19(26)27)29-11-18-13(2)25-20(30-18)14-3-5-15(6-4-14)21(22,23)24/h3-9H,10-11H2,1-2H3,(H,26,27) |
InChIKey | YDBLKRPLXZNVNB-UHFFFAOYSA-N |
密度 | 1.42±0.1 g/cm3(Predicted) |
熔点 | 134-136°C |
沸点 | 584.5±60.0 °C(Predicted) |
闪点 | 307.321°C |
蒸汽压 | 0mmHg at 25°C |
溶解度 | DMSO: 可溶20mg/mL,澄清 |
折射率 | 1.619 |
酸度系数 | 3.17±0.10(Predicted) |
存储条件 | -20°C |
稳定性 | 光敏 |
外观 | 粉末 |
颜色 | white to beige |
BRN | 18515150 |
体外研究 | GW 501516 is shown to be the most potent and selective PPARα agonists known with an EC 50 of 1.1 nM against PPARα and 1000-fold selectivity over the other human subtypes, PPARα and-γ. GW 501516 exerts anti-inflammatory effects in mouse cultured proximal tubular (mProx) cells. GW 501516 inhibits palmitate- and TNFα-induced increases in MCP-1 mRNA expression in a dose-dependent manner. |
体内研究 | GW 501516 causes impaired bone formation, leading to decreased BMD and deterioration of bone properties in OVX rats. GW 501516 attenuates interstitial inflammation and proximal tubular cell damage in a protein-overload mouse nephropathy model. GW 501516 treatment enhances running endurance and the proportion of succinate dehydrogenase (SDH)-positive muscle fibres in both trained and untrained mice. |
WGK Germany | 3 |
RTECS | AI9105500 |
微信搜索化工百科或扫描下方二维码,添加化工百科小程序,随时随地查信息!